Chemoinformaics analysis of Atractylenolide II
| Molecular Weight | 232.323 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 16 |
| Exact Molecular Weight | 232.146 | nRing | 3 |
| Solubility: LogS | -4.051 | nHRing | 1 |
| Solubility: LogP | 3.879 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.691 |
| Synth | 4.349 |
| Natural Product Likeliness | 2.272 |
| NR-PPAR-gamma | 0.079 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.699 |
| MDCK | 0.0000239 |
| BBB | 0.336 |
| PPB | 0.969726 |
| VDSS | 1.419 |
| FU | 0.0365438 |
| CYP1A2-inh | 0.346 |
| CYP1A2-sub | 0.63 |
| CYP2c19-inh | 0.103 |
| CYP2c19-sub | 0.683 |
| CYP2c9-inh | 0.261 |
| CYP2c9-sub | 0.657 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.872 |
| CYP3a4-inh | 0.105 |
| CYP3a4-sub | 0.191 |
| CL | 7.879 |
| T12 | 0.369 |
| hERG | 0.003 |
| Ames | 0.046 |
| ROA | 0.279 |
| SkinSen | 0.312 |
| Carcinogencity | 0.552 |
| EI | 0.264 |
| Respiratory | 0.882 |
| NR-Aromatase | 0.803 |
| Antiviral | Yes |
| Prediction | 0.846219 |